JPWO2021171034A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021171034A5 JPWO2021171034A5 JP2022551825A JP2022551825A JPWO2021171034A5 JP WO2021171034 A5 JPWO2021171034 A5 JP WO2021171034A5 JP 2022551825 A JP2022551825 A JP 2022551825A JP 2022551825 A JP2022551825 A JP 2022551825A JP WO2021171034 A5 JPWO2021171034 A5 JP WO2021171034A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- composition according
- glycopyrrolate
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025203938A JP2026035711A (ja) | 2020-02-27 | 2025-11-26 | エンシフェントリンおよびグリコピロレートを含む液体医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2002786.8A GB202002786D0 (en) | 2020-02-27 | 2020-02-27 | Liquid pharmaceutical composition |
| GB2002786.8 | 2020-02-27 | ||
| PCT/GB2021/050496 WO2021171034A1 (en) | 2020-02-27 | 2021-02-26 | Liquid pharmaceutical composition comprising ensifentrine and glycopyrrolate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025203938A Division JP2026035711A (ja) | 2020-02-27 | 2025-11-26 | エンシフェントリンおよびグリコピロレートを含む液体医薬組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023516630A JP2023516630A (ja) | 2023-04-20 |
| JP2023516630A5 JP2023516630A5 (https=) | 2024-02-29 |
| JPWO2021171034A5 true JPWO2021171034A5 (https=) | 2024-02-29 |
| JP7781762B2 JP7781762B2 (ja) | 2025-12-08 |
Family
ID=70278709
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551825A Active JP7781762B2 (ja) | 2020-02-27 | 2021-02-26 | エンシフェントリンおよびグリコピロレートを含む液体医薬組成物 |
| JP2025203938A Pending JP2026035711A (ja) | 2020-02-27 | 2025-11-26 | エンシフェントリンおよびグリコピロレートを含む液体医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025203938A Pending JP2026035711A (ja) | 2020-02-27 | 2025-11-26 | エンシフェントリンおよびグリコピロレートを含む液体医薬組成物 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20230112220A1 (https=) |
| EP (2) | EP4110292B1 (https=) |
| JP (2) | JP7781762B2 (https=) |
| KR (1) | KR20220149669A (https=) |
| CN (1) | CN115279343A (https=) |
| AU (1) | AU2021227456A1 (https=) |
| BR (1) | BR112022016015A2 (https=) |
| CA (1) | CA3166952A1 (https=) |
| DK (1) | DK4110292T3 (https=) |
| ES (1) | ES2970571T3 (https=) |
| FI (1) | FI4110292T3 (https=) |
| GB (1) | GB202002786D0 (https=) |
| HR (1) | HRP20240288T1 (https=) |
| HU (1) | HUE065531T2 (https=) |
| IL (1) | IL295442A (https=) |
| LT (1) | LT4110292T (https=) |
| MX (1) | MX2022010014A (https=) |
| PH (1) | PH12022552278A1 (https=) |
| PL (1) | PL4110292T3 (https=) |
| PT (1) | PT4110292T (https=) |
| RS (1) | RS65330B1 (https=) |
| SI (1) | SI4110292T1 (https=) |
| SM (1) | SMT202400076T1 (https=) |
| WO (1) | WO2021171034A1 (https=) |
| ZA (1) | ZA202208763B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| WO2024088364A1 (zh) * | 2022-10-28 | 2024-05-02 | 江苏恒瑞医药股份有限公司 | 一种包含异喹啉酮类化合物的药物组合物及其制备方法 |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| CN121620356A (zh) | 2023-06-26 | 2026-03-06 | 维罗纳制药公司 | 包含恩塞芬汀的颗粒组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2208310T3 (es) | 1999-03-31 | 2004-06-16 | Vernalis Limited | Derivados de pirimido(6,1-a) isoquinolin-4-ona. |
| GB2468073B (en) * | 2008-02-26 | 2012-09-05 | Elevation Pharmaceuticals Inc | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| EP2968313B1 (en) | 2013-03-15 | 2018-01-31 | Verona Pharma PLC | Drug combination |
| CN110051627A (zh) * | 2014-09-15 | 2019-07-26 | 维罗纳制药公司 | 包含rpl554的液体吸入制剂 |
-
2020
- 2020-02-27 GB GBGB2002786.8A patent/GB202002786D0/en not_active Ceased
-
2021
- 2021-02-26 WO PCT/GB2021/050496 patent/WO2021171034A1/en not_active Ceased
- 2021-02-26 MX MX2022010014A patent/MX2022010014A/es unknown
- 2021-02-26 PL PL21709782.3T patent/PL4110292T3/pl unknown
- 2021-02-26 EP EP21709782.3A patent/EP4110292B1/en active Active
- 2021-02-26 PH PH1/2022/552278A patent/PH12022552278A1/en unknown
- 2021-02-26 DK DK21709782.3T patent/DK4110292T3/da active
- 2021-02-26 RS RS20240350A patent/RS65330B1/sr unknown
- 2021-02-26 SI SI202130101T patent/SI4110292T1/sl unknown
- 2021-02-26 SM SM20240076T patent/SMT202400076T1/it unknown
- 2021-02-26 BR BR112022016015A patent/BR112022016015A2/pt unknown
- 2021-02-26 HR HRP20240288TT patent/HRP20240288T1/hr unknown
- 2021-02-26 KR KR1020227029927A patent/KR20220149669A/ko active Pending
- 2021-02-26 CA CA3166952A patent/CA3166952A1/en active Pending
- 2021-02-26 US US17/904,816 patent/US20230112220A1/en active Pending
- 2021-02-26 JP JP2022551825A patent/JP7781762B2/ja active Active
- 2021-02-26 ES ES21709782T patent/ES2970571T3/es active Active
- 2021-02-26 FI FIEP21709782.3T patent/FI4110292T3/fi active
- 2021-02-26 CN CN202180016396.7A patent/CN115279343A/zh active Pending
- 2021-02-26 AU AU2021227456A patent/AU2021227456A1/en active Pending
- 2021-02-26 LT LTEPPCT/GB2021/050496T patent/LT4110292T/lt unknown
- 2021-02-26 IL IL295442A patent/IL295442A/en unknown
- 2021-02-26 PT PT217097823T patent/PT4110292T/pt unknown
- 2021-02-26 HU HUE21709782A patent/HUE065531T2/hu unknown
- 2021-02-26 EP EP23213674.7A patent/EP4306129A3/en active Pending
-
2022
- 2022-08-04 ZA ZA2022/08763A patent/ZA202208763B/en unknown
-
2025
- 2025-11-26 JP JP2025203938A patent/JP2026035711A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528479A5 (https=) | ||
| HRP20240288T1 (hr) | Tekući farmaceutski sastav koji sadrži ensifentrin i glikopirolat | |
| HRP20211035T1 (hr) | Tekuća formulacija za inhalaciju koja sadrži rpl554 | |
| EP1014993B1 (en) | New use for budesonide and formoterol | |
| JP2016028101A (ja) | 非刺激性の眼科用ポビドンヨード組成物 | |
| JP4434486B2 (ja) | 医薬組成物 | |
| US20100197694A1 (en) | Compositions and methods for treatment of diseases and conditions with increased vascular permeability | |
| US20100202979A1 (en) | Compositions and methods for treatment of pulmonary diseases and conditions | |
| JPWO2021171034A5 (https=) | ||
| HUE026166T2 (en) | New epoprosthenol preparation and procedure | |
| US20110244058A1 (en) | Compositions and methods for treatment of pulmonary diseases and conditions | |
| De Luca et al. | Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review | |
| JPWO2020074894A5 (https=) | ||
| WO2025162212A1 (zh) | 一种药物组合物、器官保存液及其应用 | |
| JP5674917B2 (ja) | テトラチオモリブデン酸の治療的使用 | |
| KR100706725B1 (ko) | 디아미노트리플루오로메틸피리딘의 유도체를 함유하는 폐부전 치료제 또는 예방제 | |
| JPWO2020139525A5 (https=) | ||
| JP2017500345A (ja) | モンテルカストまたはその医薬的に許容しうる塩を含む液体製剤およびその製造方法 | |
| WO2022007743A1 (zh) | 粘膜给药剂型和其应用 | |
| RU2021109697A (ru) | Фармацевтические композиции, содержащие RPL554 в HFA-134A для введения посредством ингаляции | |
| RU2022103508A (ru) | Фармацевтическая композиция, содержащая энсифентрин | |
| NZ767295B2 (en) | Liquid Inhalation Formulation Comprising RPL554 | |
| NZ729796B2 (en) | Liquid inhalation formulation comprising rpl554 | |
| Stokes | Effects of infection on function and development of the lung | |
| RU2025101365A (ru) | Энсифентрин (rpl-554) для снижения частоты и/или тяжести обострений хобл |